Researchers at the University of Vienna have developed gut-stable oxytocin analogues designed for targeted treatment of ...

A research team at the University of Vienna, led by medicinal chemist Markus Muttenthaler, has developed a new class of oral ...

A research team has developed a new class of oral peptide therapeutic leads for treating chronic abdominal pain. This groundbreaking innovation offers a safe, non-opioid-based solution for conditions ...